share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jan 2 00:00
Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 1,325 shares of common stock on 01/02/2024, as per the latest filing. The shares, acquired through a restricted stock vest on 12/30/2023, are to be sold at an aggregate market value of $4,691.56. This transaction follows a period where no other securities were sold by Burnett in the past three months.
Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 1,325 shares of common stock on 01/02/2024, as per the latest filing. The shares, acquired through a restricted stock vest on 12/30/2023, are to be sold at an aggregate market value of $4,691.56. This transaction follows a period where no other securities were sold by Burnett in the past three months.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more